Unichem Laboratories Ltd Quarterly Results
Q1 FY26-27 Results Summary
Revenue
The revenue stands at ₹632.62 crore, reflecting a quarter-on-quarter *(QoQ) increase of 10.00 per cent from ₹575.12 crore. This corresponds to a year-on-year *(YoY) growth of 20.13 per cent.
Operating Profit
Operating Profit stands at ₹69.94 crore, reflecting a quarter-on-quarter *(QoQ) increase of 98.02 per cent from ₹35.32 crore. This corresponds to a year-on-year *(YoY) growth of 210.98 per cent.
PBDT
PBDT stands at ₹78.93 crore, reflecting a quarter-on-quarter *(QoQ) increase of 59.78 per cent from ₹49.40 crore. This corresponds to a year-on-year *(YoY) growth of 246.64 per cent.
Profit Before Tax
Profit Before Tax stands at ₹48.99 crore, reflecting a quarter-on-quarter *(QoQ) increase of 160.72 per cent from ₹18.79 crore. This corresponds to a year-on-year *(YoY) growth of 643.13 per cent.
Net Profit
Net Profit stands at ₹41.47 crore, reflecting a quarter-on-quarter *(QoQ) increase of 280.11 per cent from ₹10.91 crore. This represents a 496.08 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Unichem Laboratories Ltd News
Unichem Laboratories Ltd Earnings
- YOY
- QOQ
Unichem Laboratories Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Unichem Laboratories Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Unichem Laboratories Ltd Financial Reports
Unichem Laboratories Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Unichem Labs. | 0.73% | -5.49% | -8.78% | 46.20% | 45.08% | 6.46% |
| Gufic BioScience | -0.71% | -2.90% | 6.26% | 49.92% | 42.17% | 15.29% |
| Novartis India | -0.35% | -0.49% | -5.47% | 33.93% | 86.11% | 69.48% |
| Guj. Themis Bio. | 1.07% | -2.15% | -3.18% | 1.48% | 2.42% | -2.54% |
| Aarti Drugs | -1.58% | -6.63% | -1.72% | 12.39% | 9.67% | -18.55% |
| Kwality Pharma | 4.54% | 8.84% | 30.27% | 96.37% | 147.90% | 260.08% |
| Advanced Enzyme | 0.46% | 2.23% | -4.20% | -15.97% | 1.70% | -1.28% |
Company Info
Company Information
Chairman(Non Exe)&Dir(Non-Ind) : Prakash A Mody
Managing Director & CEO : Pabitra Bhattacharya
Non-Exec & Non-Independent Dir : Pranay Godha
Independent Non Exe. Director : Anand T Kusre
Independent Non Exe. Director : Arun Todarwal
Independent Non Exe. Director : Swati Patankar
HEAD - LEGAL / CS / CHIEF COMPLIANCE OFFICER : Pradeep Bhandari